The development of allopurinol.
D000493:Allopurinol / Q000009:adverse effects / Q000266:history* / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D002621:Chemistry; D003327:Coronary Disease / Q000097:blood; D006073:Gout / Q000150:complications / Q000188:drug therapy; D049673:History, 20th Century; D006801:Humans; D006973:Hypertension / Q000097:blood; D007951:Leukemia, Myeloid / Q000188:drug therapy; D009316:National Institutes of Health (U.S.) / Q000266:history; D009395:Nephritis, Interstitial / Q000378:metabolism; D011687:Purines / Q000266:history / Q000378:metabolism; D014481:United States; D014527:Uric Acid / Q000097:blood / Q000652:urine; D014545:Urinary Calculi / Q000378:metabolism; D014969:Xanthine Oxidase / Q000378:metabolism
D011687:Purines; D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase